Literature DB >> 7781773

Calponin reduces shortening velocity in skinned taenia coli smooth muscle fibres.

A Jaworowski1, K I Anderson, A Arner, M Engström, M Gimona, P Strasser, J V Small.   

Abstract

Calponin (4.1-5.9 microM, pig stomach) inhibited maximal shortening velocity (Vmax) by 20-25% with only minor influence on force in skinned smooth muscle from guinea-pig taenia coli activated at different Ca2+ levels and with thiophosphorylation. Similar results were obtained with a fragment of the N-terminal 1-228 amino acids engineered using a mouse cDNA construct (5.4 microM). Both the native calponin and the fragment inhibited actin filament sliding in a graded manner in an in vitro motility assay. We conclude that calponin influences the kinetics of the actin-myosin interaction in the organised smooth muscle contractile system and that engineered fragments of calponin can be used to probe its action in muscle fibres. The effects can be due to an introduction of an internal load during filament sliding, possibly by decreasing the detachment rates and increasing the cross-bridge time spent in the attached state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781773     DOI: 10.1016/0014-5793(95)00451-e

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  The maximal velocity of vascular smooth muscle shortening is independent of the expression of calponin.

Authors:  C Facemire; F V Brozovich; J P Jin
Journal:  J Muscle Res Cell Motil       Date:  2000-05       Impact factor: 2.698

2.  A role for serine-175 in modulating the molecular conformation of calponin.

Authors:  J P Jin; M P Walsh; C Sutherland; W Chen
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

3.  Impaired arterial pressure regulation during exercise due to enhanced muscular vasodilatation in calponin knockout mice.

Authors:  Shizue Masuki; Michiko Takeoka; Shun'ichiro Taniguchi; Minesuke Yokoyama; Hiroshi Nose
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

Review 4.  Calponin (CaP) as a latch-bridge protein--a new concept in regulation of contractility in smooth muscles.

Authors:  Pawel T Szymanski
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

5.  Effects of h1-calponin ablation on the contractile properties of bladder versus vascular smooth muscle in mice lacking SM-B myosin.

Authors:  Gopal J Babu; Gerard Celia; Albert Y Rhee; Hisako Yamamura; Katsuhito Takahashi; Frank V Brozovich; George Osol; Muthu Periasamy
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

6.  Slow cycling of unphosphorylated myosin is inhibited by calponin, thus keeping smooth muscle relaxed.

Authors:  U Malmqvist; K M Trybus; S Yagi; J Carmichael; F S Fay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

7.  Cytoskeletal reorganization evoked by Rho-associated kinase- and protein kinase C-catalyzed phosphorylation of cofilin and heat shock protein 27, respectively, contributes to myogenic constriction of rat cerebral arteries.

Authors:  Alejandro Moreno-Domínguez; Ahmed F El-Yazbi; Hai-Lei Zhu; Olaia Colinas; X Zoë Zhong; Emma J Walsh; Dylan M Cole; Gary J Kargacin; Michael P Walsh; William C Cole
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 8.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

9.  Contractile properties and proteins of smooth muscles of a calponin knockout mouse.

Authors:  J D Matthew; A S Khromov; M J McDuffie; A V Somlyo; A P Somlyo; S Taniguchi; K Takahashi
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

Review 10.  Smooth, slow and smart muscle motors.

Authors:  Anders Arner; Mia Löfgren; Ingo Morano
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.